Nektar Therapeutics (NKTR)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1.34% | 77,353 | 0.02 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 17.21% | 977,404 | 0.27 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 9.48% | 491,584 | 0.15 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 5.88% | 288,236 | 0.14 | |
| Q1 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 51.13% | 1,657,167 | 0.62 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 3,241,234 | 1.02 | |
| Q4 2018 | |||||
| ≡ | Meridian Contrarian Fund | Add 25.38% | 50,000 | 0.33 | |
| Q2 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 15.04% | 60,000 | 0.22 | |
| Q1 2016 | |||||
| ≡ | Meridian Contrarian Fund | Add 24.17% | 91,988 | 0.25 | |
| Q3 2015 | |||||
| ≡ | Meridian Contrarian Fund | Add 9.49% | 33,000 | 0.07 | |
| Q1 2015 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 347,605 | 0.59 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.